TSE: 4540 - Tsumura & Co.

Yield per half year: -14.7%
Dividend yield: +3.77%
Sector: Healthcare

Tsumura & Co.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
17.7 111.07 -84.06% 15.58 +13.64%
P/S 1.96 74.11 -97.35%
P/BV 1 70.33 -98.58%
P/FCF -13.99 94.48 -114.81%
Ev/Ebitda 9.66 20.14 -52.03%
Ev/S 1.97 71.71 -97.25%
Ev/FCF -20.58 28.33 -172.64%
E/P 0.0827 -0.0497 -266.48%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
20.4 -33.93 -160.12% 22.08 -7.63%
ROE 6.39 -12 -153.24%
ROA 4.05 -11.69 -134.66%
ROIC 6.51 9.09 -28.42%
ROS 11.08 -127.68 -108.68%
ROCE 6.78 -2.42 -379.98%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
5/10
2.59 -0.2574 -1106.01% 2.21 +17.02%
Nеt Debt/Ebitda 0.0525 12.67 -99.59%
Debt/Ratio 0.1861 0.1476 26.04%
Debt/Equity 0.4499 1.1 -59.26%
Debt/Net Income 4.77 -2.63 -281.42%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
9.43/10
3.77 2.85 32.5% 3.04 +24.08%
Number of years of dividend growth 0 1.54 -100%
DSI 0.8571 0.7279 17.75%
Average dividend growth 4.54 -33.3 -113.62%
Average percentage for 5 years 3.04 2.17 39.85%
Average percentage for payments 31.11 33.94 -8.33%
Difference from average difference in sector 0.9247

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
22.39 78.06 -71.32%
Growth impulse Ebitda in 5 years 17.05 60.11 -71.64%
Growth impulse Net Income in 5 years 21.33 57.22 -62.72%
Growth impulse FCF in 5 years -289.12 20.48 -1511.72%
Growth impulse EPS in 5 years 22.15 191.41 -88.43%
IP Score
5.48/10

Similar companies

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription